Novoprotein Scientific Inc. (SHA:688137)

China · Delayed Price · Currency is CNY

40.53

+5.07 (14.30%)

At close: Aug 4, 2026

Novoprotein Scientific Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	150.24	146.44	127.56	153.19	264.55	341.9
Revenue Growth	11.36%	14.80%	-16.73%	-42.09%	-22.62%	90.11%
Gross Profit	76.61	71.25	54.08	82.5	210.25	287.35
Operating Income	-89.03	-92.25	-100.31	-49.22	81.98	176.17
Net Income	-76.58	-77.78	-54.42	12.84	90.72	149.01
Earnings Per Share	-1.09	-1.11	-0.78	0.18	1.59	3.73
EPS Growth	-	-	-	-88.68%	-57.37%	-28.67%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	141.14
Overseas sales	4.93
Total	146.07

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	772.94	1,710	1,801	1,890	1,897	189.39
Total Debt	52.55	55.61	66.42	73.31	83.15	87.04
Net Cash (Debt)	720.39	1,654	1,735	1,817	1,814	102.36
Net Cash Growth	15.13%	-4.64%	-4.50%	0.16%	1671.86%	9.09%
Net Cash Per Share	10.24	23.61	24.87	25.46	31.79	2.56

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-14.17	-13.36	13.32	69.16	3.38	70.97
Capital Expenditures	-78.17	-78.89	-44.88	-44.94	-36.77	-69.95
Free Cash Flow	-92.34	-92.25	-31.57	24.22	-33.39	1.02
Free Cash Flow Growth	-	-	-	-	-	-98.82%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	50.99%	48.66%	42.40%	53.85%	79.47%	84.05%
Operating Margin	-59.26%	-63.00%	-78.64%	-32.13%	30.99%	51.53%
Pretax Margin	-43.94%	-48.06%	-42.51%	4.06%	40.14%	51.54%
Profit Margin	-50.97%	-53.12%	-42.66%	8.38%	34.29%	43.58%
FCF Margin	-61.46%	-62.99%	-24.75%	15.81%	-12.62%	0.30%

Dividends

Fiscal Year	FY 2023	FY 2022
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.500	0.500
Dividend Per Share Growth	0%	-
Dividend Yield	0.92%	0.68%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	-	303.14	58.79	-
P/FCF Ratio	-	-	-	160.75	-	-
PS Ratio	18.79	19.08	18.17	25.42	20.16	-